News & Perspective

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Nov 02, 2007

Nov 02, 2007

North American countries agree to coordinate infectious disease efforts

(CIDRAP News) – The United States, Canada, and Mexico yesterday vowed to help each other during public health emergencies and outlined the types of aid they could provide and accept from each other in the event of a pandemic or other infectious disease outbreak.

Aug 16, 2007

Aug 16, 2007

Glaxo sells more H5N1 vaccine to US, launches trial

(CIDRAP News) – The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.

Jul 18, 2007

Jul 18, 2007

HHS, DHS fund public health preparedness and emergency response

(CIDRAP News) – The US Department of Health and Human Services (HHS) yesterday announced it was providing states, US territories, and four metropolitan areas with $896.7 million in public health preparedness funding, with $175 million of the total earmarked for pandemic planning.

Preparedness grantsThe bulk of the money is allocated toward Public Health Emergency Cooperative Agreements, which public health departments use to build capacity.

May 16, 2007

May 16, 2007

Syndromic surveillance: faulty alarm system or useful tool?

(CIDRAP News) – At first glance, the Web page looks like an overhead shot of a fantastic game board: a map—identifiably Los Angeles—sprinkled with faceted roundels in a half-dozen colors.

Jan 05, 2007

Jan 05, 2007

HHS awards $102 million for new flu drug

(CIDRAP News) – In an effort to expand the pool of antiviral drugs for influenza, the US government yesterday awarded a $102.6 million contract to BioCryst Pharmaceuticals Inc. of Birmingham, Ala., to develop peramivir, a new neuraminidase inhibitor.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»